No connection

Search Results

BMA

BEARISH
$96.63 Live
Banco Macro S.A. · NYSE
Target $112.81 (+16.7%)
$38.3 52W Range $104.0

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$6.81B
P/E
38.35
ROE
5.5%
Profit margin
8.6%
Debt/Equity
N/A
Dividend yield
2.55%

AI Analysis

AI-powered fundamental assessment

Confidence
78%
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant operational and profitability concerns. Despite a bullish analyst recommendation and strong long-term price appreciation, the company faces deteriorating fundamentals, including negative operating margins, a steep decline in year-over-year revenue and earnings, and extremely stretched valuation metrics. The stock trades at a massive premium to both the Graham Number ($17.18) and intrinsic value estimate ($17.64), with a current price of $96.63, suggesting substantial overvaluation. While dividend yield and recent technical rebound offer some support, the underlying financial deterioration and lack of transparency in key leverage and liquidity metrics amplify downside risk.

Key Strengths

Analyst consensus supports a 'buy' rating with a high target price of $112.81, implying 16.7% upside.
Recent technical performance shows strong recovery: +34.8% over 6 months and +6.2% in the last month.
Dividend yield of 2.55% is supported by a reasonable payout ratio of 42.03%.
Long-term price appreciation has been exceptional: +868.3% over 5 years.
Profit margin of 8.58% remains positive despite sector-wide challenges.

Key Risks

Critically low Piotroski F-Score of 2/9 signals weak financial health, particularly in profitability and leverage trends.
Operating margin is deeply negative at -4.96%, indicating core business unprofitability.
Revenue growth has collapsed YoY by -28.70%, reflecting severe top-line contraction.
Current P/E of 38.35 is extremely high compared to forward P/E of 9.81, suggesting earnings recovery is priced in prematurely.
Extreme valuation disconnect: stock trades at 5.6x the Graham Number and 5.5x intrinsic value, with no Altman Z-Score to offset risk.
AI Fair Value Estimate
Based on comprehensive analysis
$17.5
-81.9% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
34
Weak
Value
18
Future
25
Past
40
Health
20
Dividend
65
AI Verdict
High-risk, overvalued financial with deteriorating fundamentals despite bullish price action.
Key drivers: Low Piotroski F-Score, Negative operating margin, Massive valuation premium, Collapse in revenue and earnings growth, Lack of transparency in debt and liquidity metrics
Confidence
80%
Value
18/100

Ref P/E, PEG, Graham Number

Positives
  • Forward P/E of 9.81 suggests potential earnings recovery
Watchpoints
  • Current P/E of 38.35 is extremely high
  • Price/Book of 18.56 is exceptionally elevated for a bank
  • Stock trades at 5.6x Graham Number
  • No PEG ratio due to negative growth
Future
25/100

Ref Growth rates

Positives
  • Forward P/E implies improving earnings expectations
  • Analyst target suggests confidence in recovery
Watchpoints
  • YoY EPS growth of -137.5% and Q/Q EPS growth of -120.8%
  • Revenue growth down -28.70% YoY
  • No visibility on earnings growth due to volatility
Past
40/100

Ref Historical trends

Positives
  • 5-year price return of +868.3% shows strong historical performance
  • Mixed but occasionally strong earnings surprises (e.g., +139.2% in 2019)
Watchpoints
  • Earnings volatility is extreme, with multiple large negative surprises
  • Recent quarters show deteriorating accuracy and declining actual results
  • Long-term consistency is absent
Health
20/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • ROE of 5.47% remains positive, though low
Watchpoints
  • Piotroski F-Score of 2/9 indicates severe financial weakness
  • Operating margin of -4.96% shows core operations are unprofitable
  • No Altman Z-Score available to assess bankruptcy risk
  • No data on debt/equity, current ratio, or cash/debt levels
Dividend
65/100

Ref Yield, Payout

Positives
  • Dividend yield of 2.55% is attractive in current market
  • Payout ratio of 42.03% is sustainable based on earnings
Watchpoints
  • Dividend strength score is only 50/100
  • No 5-year average yield data to assess consistency

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$96.63
Analyst Target
$112.81
Upside/Downside
+16.7%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BMA and closest competitors.

Updated 2026-01-23
BMA
Banco Macro S.A.
Primary
5Y
+868.3%
3Y
+446.6%
1Y
-7.7%
6M
+34.8%
1M
+6.2%
1W
+4.3%
MOR
Morningstar, Inc.
Peer
5Y
-24.2%
3Y
-15.7%
1Y
-38.6%
6M
-23.1%
1M
-5.4%
1W
-2.5%
RIO
Riot Platforms, Inc.
Peer
5Y
-55.7%
3Y
+34.6%
1Y
+180.3%
6M
-9.6%
1M
+28.4%
1W
+9.1%
STE
StepStone Group Inc.
Peer
5Y
+85.3%
3Y
+171.4%
1Y
+19.9%
6M
-9.8%
1M
+17.6%
1W
+19.7%
MKT
MarketAxess Holdings Inc.
Peer
5Y
-65.4%
3Y
-45.9%
1Y
-20.2%
6M
+1.9%
1M
-3.1%
1W
-0.3%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
38.35
Forward P/E
9.81
PEG Ratio
N/A
P/B Ratio
18.56
P/S Ratio
0.0
EV/Revenue
-0.11
EV/EBITDA
N/A
Market Cap
$6.81B

Profitability

Profit margins and return metrics

Profit Margin 8.58%
Operating Margin -4.96%
Gross Margin N/A
ROE 5.47%
ROA 1.32%

Growth

Revenue and earnings growth rates

Revenue Growth -28.7%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$3131.68

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-25
$N/A
2025-11-26
$-551.46
-136.3% surprise
2025-08-27
$2653.17
+78.4% surprise
2025-05-29
$756.15
+58.5% surprise

Financial Services Sector Comparison

Comparing BMA against 820 companies in the Financial Services sector (141 bullish, 351 neutral, 328 bearish)
P/E Ratio
38.35
This Stock
vs
36.01
Sector Avg
+6.5% (Premium)
Return on Equity (ROE)
5.47%
This Stock
vs
-0.73%
Sector Avg
-846.9% (Below Avg)
Profit Margin
8.58%
This Stock
vs
91.62%
Sector Avg
-90.6% (Weaker)
Revenue Growth
-28.7%
This Stock
vs
35.27%
Sector Avg
-181.4% (Slower)

Similar Companies

Peer comparison within the same industry

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
9 analysts
UBS
2025-11-19
init
Buy
Citigroup
2025-11-03
up
Neutral Buy
JP Morgan
2025-10-28
Maintains
Overweight Overweight
JP Morgan
2025-10-22
up
Neutral Overweight
HSBC
2025-10-01
up
Hold Buy
Citigroup
2025-09-11
down
Buy Neutral

Past News Coverage

Recent headlines mentioning BMA from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile